NIMHANS PhD Life Sciences Research Associate Post Vacant
Research Associate vacancy for phd life sciences candidates at NIMHANS. NIMHANS is recruiting for research vacancies for msc life sciences candidates. NIMHANS recruitment August/September 2018. NIMHANS is hiring phd life sciences candidates. Interested and eligible candidates check out all of the details below:
This job expires in :
Post Title: Research Associate (One)
Project Name: “Yoga based Intervention for Opioid Dependence: Efficacy and Potential Mechanisms”
Principal Investigator: Dr Hemant Bhargav
Emoluments per month: Rs.36,000/- + 30 percent HRA
Duration: Initial appointment will be for 6 months that is extendable annually for 3 years based on satisfactory performance of the candidate.
- Ph. D degree in almost any area of science/Life science/Medicine/Physiology/Neuroscience with great academic record. People who have already submitted the thesis will also be qualified to apply (attach evidence of submission from the Registrar/Controller of assessments ).
- People who have research expertise in maximizing Human Magnetic Resonance Neuroimaging protocols, investigations and acquisitions will be favoured.
Maximum age limit: 40 Years
How to Apply:
Eligible candidates meeting the standards, may apply on a plain paper with their curriculum vitae, age proof and a copy of testimonials by email to [email protected] applicants that apply should always mention the Notification No. & Date, email ID, Contact No. & Postal address, failing which the application won’t be considered.
The final date for receipt of filled in applications along with the applicable documents is 10.09.2018 around 4.00 p.m Late applications won’t be entertained.
Deadline: 10.09.2018 around 4.00 p.m
View Notification Below
Editor’s Note: phd life sciences jobs, life sciences jobs, phd life sciences, life sciences careers, research careers, nimhans jobs, nimhans careers, nimhans recruitment. Check out the Biotecnika Times Newsletter – make sure you are subscribed to it and also follow us on Twitter and Facebook.